In the first of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, Dr. Stefano Bertozzi, director of HIV and tuberculosis programs at the Foundation, gives his thoughts on what lies ahead this year in HIV and TB building on key developments from the past year and a half. In his role, Dr. Bertozzi oversees grants in HIV vaccine development, biomedical prevention research, diagnostics development and resistance monitoring, and strategies for introduction and scaling-up of interventions. He has held past leadership roles at UNAIDS, the World Health Organization, the World Bank, and the National Institute of Public Health (INSP) in Mexico.
White House proposals to slash more than a billion dollars from U.S. supported HIV responses and limit efforts to control the epidemic to a handful of […]
Researchers at the University of Cape Town in South Africa have identified a sequence of biological processes that occur as tuberculosis infection progresses to active pulmonary […]
In time for meetings of international leaders, 2016 boost in TB investments sets new — but low — bar, as well as impetus to gain on […]
Antibiotics and antimalarial drugs are most frequently reported as substandard and falsified to the World Health Organization’s Global Surveillance and Monitoring system for such medical products, […]